Skip to main content
. 2022 Jun 16;6(7):503–511. doi: 10.1002/jgh3.12780

Figure 1.

Figure 1

Changes from baseline in (a) body weight, (b) body mass index (BMI), (c) platelets, (d) aspartate aminotransferase (AST), (e) alanine aminotransferase (ALT), and (f) gamma glutamyl transpeptidase (γ‐GTP) in patients treated with oral semaglutide for 24 weeks. Error bars show the interquartile range. *P < 0.05, **P < 0.01 versus baseline.